Ranbaxy acquisition to hit FY16 profit: Sun Pharma
The company says that consolidated profit and revenue could be adversely impacted due to the expenses arising out of integration of Ranbaxy with Sun Pharma.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
